Takuma Nakatsuka, Ryosuke Tateishi, Masaya Sato, Natsuka Hashizume, Ami Kamada, Hiroki Nakano, Yoshinori Kabeya, Sho Yonezawa, Rie Irie, Hanako Tsujikawa, et al. Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease. Hepatology (Baltimore, Md.). 2024
Kazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, Hisateru Tachimori, Koji Uchino, Ryo Nakagomi, Tomoharu Yamada, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, et al. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL). Scientific reports. 2024. 14. 1. 2826-2826
Kotaro Soeda, Takayoshi Sasako, Kenichiro Enooku, Naoto Kubota, Naoki Kobayashi, Yoshiko Matsumoto Ikushima, Motoharu Awazawa, Ryotaro Bouchi, Gotaro Toda, Tomoharu Yamada, et al. Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis. Nature communications. 2023. 14. 1. 6584-6584
Makoto Moriyama, Ryosuke Tateishi, Mizuki Nishibatake Kinoshita, Tsuyoshi Fukumoto, Tomoharu Yamada, Taijiro Wake, Ryo Nakagomi, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, et al. Impact of nucleos(t)ide analogues on the risk of hepatocellular carcinoma in chronic hepatitis B patients: A time-dependent Cox regression analysis. 2023
Sachiko Kanai, Hiroaki Fujiwara, Suguru Mizuno, Takahiro Kishikawa, Takuma Nakatsuka, Tsuyoshi Hamada, Mariko Tanaka, Junichi Arita, Yousuke Nakai, Hiroyuki Isayama, et al. Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2023